Advanced
Synthesis of New 8-Formyl-4-methyl-7-hydroxy Coumarin Derivatives
Synthesis of New 8-Formyl-4-methyl-7-hydroxy Coumarin Derivatives
Journal of the Korean Chemical Society. 2012. Aug, 56(4): 459-463
Copyright © 2012, The Korean Chemical Society
  • Received : January 13, 2012
  • Accepted : June 13, 2012
  • Published : August 20, 2012
Download
PDF
e-PUB
PubReader
PPT
Export by style
Article
Author
Metrics
Cited by
TagCloud
About the Authors
D. M. Manidhar
K. Uma Maheswara Rao
N. Bakthavatchala Reddy
Ch. Syama Sundar
C. Suresh Reddy
csrsvu@gmail.com

Abstract
8-Formyl-4-Methyl-7-Hydroxy Coumarin Derivatives were synthesized via Penchem condensation followed by Duffs reaction. Treatment of this with N,N-di substituted cyano acetamides in the presence of piperdine afforded New 8-Formyl-4-Methyl-7-Hydroxy Coumarin Derivatives ( 7a-o ). Their structures were characterized by IR, 1 H and 13 C NMR and Mass spectral and elemental analysis data.
Keywords
INTRODUCTION
Coumarin is a pleasanty fragrant benzopyrone compound, found in many plants, notably in high concentration in the tonka bean (Dipteryx odorata), vanilla grass (Anthoxanthum odoratum), sweet woodruff (Galium odoratum), mullein (Verbascum spp.), sweet grass (Hierochloe odorata), Cassia cinnamon (Cinnamomum aromaticum) and sweet clover. Natural products with coumarin moiety and have wide range of biological activity. They are used as drugs, intermediates and pesticides. 1 They are found to have anti-coagulant, inflammatory microbial, 2 oxidant, 3 HIV, allergic, cancer, 4 proliferative and viral 5 properties. 4-methyl-7-hysroxy coumarin has similar structure of Scopoletin, an alkaloid which is isolated from medicinal plant (Gelsemium Seperiven) has an anti-cancer activity. Recently 4-methyl-7-hydroxy coumarin has been reported to have anti skin-cancer activity. 6
Coumarin has clinical medical value by itself, as an edema modifier. Coumarin and other benzopyrones, such as 5,6 benzopyrone, 1,2 benzopyrone, diosmin and others stimulate macrophages and degrade extracellular albumen, allowing faster resorption of edematous fluids.
Coumarin itself has no anticoagulant activity but is transformed into the natural anticoagulant called dicoumarol by a number of fungi species. This occurs as the result of the production of 4-hydroxycoumarin, then further (in the presence of naturally occurring formaldehyde) into the actual anticoagulant dicoumarol, a fermentation product and mycotoxin. This substance was responsible for the bleeding disease known historically as “sweet clover disease” in cattle eating moldy sweet clover silage.
EXPERIMENTAL
- Materials and Methods
Melting points were determined on Buchi-540 melting point apparatus and are un-corrected. FT-IR spectra were recorded as KBr pellet on Nicolet-380 FT-IR instrument (Model Thermo Electron corporation-Spectrum one), 1 H and 13 C NMR (proton decoupled) spectra were recorded on Varian 300 MHz spectrometer using DMSO-d 6 and CDCl 3 as solvent. Mass spectra were recorded on Agilent triple quadrapole mass spectrometer equipped with turbo ion spray interface at 360 ℃.
- Synthesis of 4-Methyl-7-hydroxy Coumarin of 27
Concentrated sulfuric acid (20 mL) was added to a 100 mL round bottom flask and cooled to 0-5 ℃ in an ice bath. A solution of resorcinol (0.001 mol) in ethyl acetoacetate (0.0015 mol) was added to sulfuric acid under constant stirring at 0-5 ℃. The reaction mass was stirred over night at room temperature and poured in to crushed ice under vigorous stirring. An off-white solid obtained was filtered and recrystallised in ethanol. m.p: 180-182 ℃; 1 H NMR (300MHz, CDCl 3 ): δ 2.49 (s, 3H, C4-CH 3 ), 6.31 (s, 1H, C3-H), 6.92 (d, 1H, C6-H, J =9.0 Hz), 6.94 (s, 1H, C8-H), 7.57 (d, 1H, C5-H, J =9.0 Hz); IR (KBr, ν max): 3423 (-OH), 1733 (-CO), 1555 (-C=C-) cm -1 .
- Synthesis of 4-Methyl-7-hydroxy-8-formyl Coumarin 38
7-hydroxy-4-methyl-coumarin (2) (0.001 mol) was dissolved in glacial acetic acid (20 mL) and hexamethylene tetramine (0.003 mol) was added to the reaction mixture. Heated to 80-85 ℃ in a water bath for 6.0 hr. A hot mixture of 5 mL water and 30 mL hydrochloric acid was added, kept for 30 min. and cooled to room temperature. It was extracted with diethyl ether. And on evaporation of ether, a pale yellow solid was obtained. Yield: 22%; m.p. 176-178 ℃; 1 H NMR (300 MHz, CDCl 3 ): δ 2.44 (s, 3H, C4-CH 3 ), 6.22 (s, 1H, C3-H), 6.90-6.93 (d, 1H, C6-H, J =9 Hz), 7.73-7.76 (d, 1H, C5-H, J =9 Hz), 10.63 (s, 1H, HCO), 12.28 (s, 1H, OH); IR (KBr, ν max): 3442(-OH), 1742 (-CO), 1644(-CHO), 1594(-C=C-) cm -1 .
- Synthesis of N,N-di substituted cyano acetamide Derivatives (6 a-o)9,10
General procedure:
Amine (0.001 moles) was dissolved in 10 ml ethanol, 0.0012 moles of ethyl cyano acetate was added and stirred for 5.0 hr at reflux. Cooled the mass to 0-5 ℃ and filtered, which were used directly in the next step. Yields were varied from 60-70%.
- Synthesis of 7a-o by Knoevengel Condensation of 3 & 6a-o11
General procedure:
8-formyl-4-methyl-7-hydroxy Coumarin (3) (0.001 mol) was dissolved in 10mL ethanol containing N,N di substituted cyanoacetamide derivatives (6a-o) (0.001 mol) and catalytic amount of piperidine. Refluxed for 2.0 hr, cooled to 0-5 ℃ and filtered the solid. Pale yellow to orange red color solids were obtained. Yields varied from 50-60%.
PPT Slide
Lager Image
Synthesis of 4-methyl-7-hydroxy-8-formyl coumarin.
PPT Slide
Lager Image
Synthesis of N,N-di substituted cyano acetamide derivatives (6 a-o).
PPT Slide
Lager Image
Synthesis of 7a-o by Knoevengel condensation of 3 & 6a-o.
SPECTRAL DATA
- (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-N-(1-(4-methoxyphenyl)ethyl) acryl amide (7a)
IR (KBr cm -1 ): 3437 (-OH), 3275 (-NH), 2240 (-CN), 1729 (-CO, cyclic), 1624 (-CO), 1557 (-C=C-): 1 H NMR (DMSO- d 6 ): δ 11.8 (s, -OH), 8.9 (s, H, -NH), 8.5 (s, H, exocyclic CH=C), 6.9-7.2 (m, 4H, phenyl), 6.0-6.5 (m, 2H, coumarin ring), 5.0 (q, H, -C H -NH), 3.8 (s, 3H, -OCH 3 ), 2.45 (s, 3H, -CH 3 ), 1.5 (d, 3H, -CH 3 ); 13 C NMR (DMSO- d 6 ): δ 160.8 (C-2), 160 (C=O), 158.9 (C-1'), 155 (C-7), 153.4 (C-exocyclic), 153 (C-4), 146 (C-10), 133 (C-4'), 126.5 (C-3', C-5'), 125.2 (C-5), 118.2 (C-8), 115 (-CN), 114.0 (C-2', C-6', C-6), 112.5 (C-3), 112.0 (C-9), 103 (C-exocyclic), 56.1 (-OCH 3 ), 49.0 (C, - C H-NH ), 21.5 (C, -CH 3 ), 19.5 (-CH 3 of C-4); MS: m/z(M + +1) 405.4; Anal. Calcd for C 23 H 20 N 2 O 5 : C, 68.31; H, 4.98; N, 6.93; O, 19.78, Found: C, 68.29; H, 4.89; N, 6.91; O,19.8.
- (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-N-(1-phenylethyl) acrylamide (7b)
IR (KBr, cm -1 ): 3442 (-OH), 2257 (-CN), 3275 (-NH), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); 1 H NMR (DMSO- d 6 ): δ 11.7 (s, H, -OH), 8.9 (s, H, -NH), 8.5 (s, H, exocyclic CH=C), 6.5-7.4 (m, 5H, phenyl), 6.0-6.4 (m, 2H, coumarin ring), 6.23 (d, 1 H, endocyclic), 5.0 (q, H, -C H -NH), 2.5 (s, 3H, CH 3 ), 1.5 (d, 3H, CH 3 ); 13 C NMR (DMSO- d 6 : δ 164.5 (C-4'), 160.7 (C-2), 159 (-CO), 155 (C-7), 153.5 (C, exocyclic ethylene), 152.5 (C-4), 146.8 (C-10), 128.7 (C-2', C-6'), 127 (C-3', C-5'), 126 (C-1'), 125 (C-5), 118 (C-8), 116 (-CN), 114.5 (C-6), 112.5 (C-3), 112 (C-9), 103 (C-exocyclic), 49 (- C H-NH-), 22 (-CH 3 ), 21.5 (-CH 3 ); MS: m/z(M + +1) 375.0; Anal. Calcd for C 22 H 18 N 2 O 4 : C, 70.58; H, 4.85; N, 7.48; O, 17.09 Found C, 70.55; H, 4.80; N, 7.50; O, 17.0.
- (E)-N-benzyl-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)acrylamide (7c)
IR (KBr, cm -1 ): 3430 (-OH), 3275 (-NH), 2230 (-CN), 1730.4 (-CO), 1674 (cyclic -CO), 1546 (-C=C) cm -1 ; 1 H NMR(DMSO- d 6 ): δ 11.7 (s, H, -OH), 8.9 (s, H, -NH), 8.5 (s, H, exocyclic CH=C), 7.5 (d, H, coumarin ring), 6.8 (d, H, coumarin ring), 7.2-7.4 (m, 5H, phenyl), 6.0 (s, H, endocyclic), 4.5 (s, 2H, -CH 2 ), 2.5 (s, 3H, CH 3 ); 13 C NMR (DMSO- d 6 ): δ 162.7 (C-2), 160 (-CO), 155 (C-7), 153.5 (C, ethylene), 152.5 (C-4), 146 (C-10), 134 (C-4'), 128.5 (C-2', C-6'), 126.5 (C-3', C-5'), 126 (C-1'), 125.2 (C-5), 118.2 (C-7), 115 (C, -CN), 114.5 (C-6), 112.5 (C-3), 112 (C-9), 103 ( C -CN), 43.0 (C, -CH 2 ), 19.5 (C, -CH 3 ); MS: m/z(M + +1) 361.9; Anal. Calcd for C 21 H 16 N 2 O 4 : C, 69.99; H, 4.48; N, 7.77; O, 17.76. Found C, 69.89; H, 4.44; N, 7.80; O, 17.66.
- (E)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-2-(piperidine-1-carbonyl) acrylonitrile (7d)
IR (KBr, cm -1 ): 3442 (-OH), 2240.3 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); 1 H NMR (DMSO- d 6 ): δ 11.79 (s, -OH), 8.32 (s, H, exocyclic CH=C), 6.2-7.55 (m, 3H, coumarinring), 3.7 (m, 4H, piperidine), 2.5 (s, 3H, CH 3 ), 1.6 (m, 2H piperidine), 1.53 (m, 4H, piperidine); 13 C NMR (DMSO- d 6 ): δ 170.5 (CO), 160 (C-2), 155 (C-7), 153 (C, ethylene), 152.7 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-8), 115 (CN), 114.0 (C-6), 112.5 (C-3), 112.0 (C-9), 106 (C, ethylene), 47.0 (2C, piperidine), 25.0 (2C, piperidine), 24.1 (C, piperidine), 19.5 (C, -CH 3 ); MS: m/z (M + +1) 339.3; Anal. Calcd for C 19 H 18 N 2 O 4 : C, 67.44; H, 5.36; N, 8.28; O, 18.91. Found; C, 67.40; H, 5.39; N, 8.31; O, 18.20.
- (E)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-2-(pyrrolidine-1-carbonyl)acrylo nitrile (7e)
IR (KBr, cm -1 ): 3442 (-OH), 2246 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); 1 H NMR (DMSO- d 6 ): δ 11.8 (s, -OH), 8.35 (s, H, exocyclic CH=C), 6.23-7.5 (3H, coumarin), 3.25 (t, 4H, pyrrolidine), 2.43 (s, 3H, -CH 3 ), 1.72 (t, 4H, pyrrolidine); 13 C NMR (DMSO- d 6 ): δ 170.7 (-CO), 160, (C-2), 155 (C-7), 153 (C, expcyclic ethylene), 146 (C-10), 125.2 (C-5), 118.2 (C-8), 115 (-CN), 114.0 (C-6), 112.5 (C-3), 112.0 (C-9), 106 (C, ethylene), 45.7 (2C, pyrrolidine), 25.0 (2C, pyrrolidine), 19.5 (C, -CH 3 ); MS: m/z(M + +1) 325.3; Anal. Calcd for C 18 H 16 N 2 O 5 : C, 66.66; H, 4.97; N, 8.64; O, 19.73. Found; C, 66.76; H, 5.02; N, 8.54; O, 19.80.
- (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl) N-methylacrylamide (7f)
IR (KBr, cm -1 ): 3442 (-OH), 3225 (-NH), 2248 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); 1 H NMR (DMSO- d 6 ): 11.8 (s, OH), 8.4 (s, H, exocyclic ethylene), 8.1 (m, -NH), 6.22-7.5 (m, 3H, coumarin ring), 2.72 (d, 3H, -HN-CH 3 ), 2.43 (s, 3H, -CH 3 ); 13 C NMR (DMSO- d 6 ): δ 160.5 (CO), 159.7 (C-2), 155 (C-7), 153.8 (C, exocyclic ethylene), 153 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-8), 115 (CN), 114.5 (C-6), 112.5 (C-3), 112.0 (C-9), 104 (C, ethylene), 25.5 (-NH- C H 3 ), 19.5 (C, -CH 3 ); MS: m/z(M + +1): 285.3; Anal. Calcd for C 15 H 12 N 2 O 4 : C, 63.38; H, 4.25; N, 9.85; O, 22.51. Found; C, 63.80; H, 4.19; N, 9.65; O, 22.39.
- (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl) N,N-dimethylacrylamide (7g)
IR (KBr, cm -1 ): 3442 (-OH), (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); 1 H NMR (DMSO- d 6 ): 11.8 (s, -OH), 8.3 (s, H, -ethylene), 6.2-7.5 (m, 3H coumarin ring), 3.02 (d, 6H, -N(CH 3 ) 2 ), 2.43 (s, 3H, -CH 3 ); 13 C NMR (DMSO- d 6 ): δ 160.5 (-CO), 159.7 (C-2), 155 (C-7), 153 (C, exocyclic ethylene), 152.5 (C-5), 146 (C-10), 125.2 (C-3), 118.2 (C-8), 115 (-CN), 114.0 (C-6), 112.5 (C-3), 112.0 (C-5), 107 (C, ethylene), 36.6 (2C, -N(CH 3 ) 2 ), 19.5 (C, -CH 3 ); MS: m/z(M + +1): 300.0; Anal. Calcd for C 16 H 14 N 2 O 4 : C, 64.42; H, 4.73; N, 9.39; O, 21.45. Found; C, 64.24; H, 4.69; N, 9.55; O, 21.59.
- (E)-2-cyanoN,N-diethyl-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl) acrylamide (7h)
IR (KBr, cm -1 ): 3442 (-OH), 2254 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); 1 H NMR(CDCl 3 ): δ 11.8 (s, -OH), 8.3 (s, H, ethylene), 6.24-7.55 (m, 3H coumarin ring), 3.72 (q, 4H, -H 2 C-N-CH 2 ), 2.4 (s, 3H, -CH 3 ), 1.34 (t, 6H, - (CH 3 ) 2 ); 13 C NMR (CDCl 3 ): δ 160.5 (CO), 159.7 (C-2), 155 (C-7), 153 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-8), 115 (CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 106 (C, ethylene), 40.8 (q, 2C, -CH 2 ), 19.5 (C, -CH 3 ), 12.5 (t, 2C, -(CH 3 ) 2 ); MS: m/z(M + +1): 327.5; Anal. Calcd for C 18 H 18 N 2 O 4 : C, 66.25; H, 5.56; N, 8.58; O, 19.61. Found; C, 66.30; H, 5.64; N, 8.65; O, 19.16.
- (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl) N,N-diisopropylacrylamide (7i)
IR (KBr, cm -1 ): 3442 (-OH), 2244 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C); 1 H NMR (CDCl 3 ): 11.8 (s, -OH), 8.35 (s, exocyclic ethylene), 6.23-7.55 (m, 3H, coumarin ring), 4.0 (m, 2H, -CH-), 2.45 (s, 3H, -CH 3 ), 1.27 (d, 12H, 4Me of isopropyl): 13 C NMR (CDCl 3 ): δ 160.5 (CO), 159.7 (C-2), 155 (C-7), 153 (C, exocyclic ethylene), 152.7 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-8), 115 (CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 107 (C, ethylene), 47.0 (2C, -CH), 19.5 (C - CH 3 ), 21.5 (t, 4C, -4CH 3 of isopropyl); MS: m/z(M + +1): 355.4; Anal. Calcd for C 20 H 22 N 2 O 4 : C, 67.78; H, 6.26; N, 7.90; O, 18.06. Found; C, 67.87; H, 6.30; N, 8.01; O, 18.14.
- (E)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-2-(1H-imidazole-1-carbonyl)acrylo nitrile (7j)
IR (KBr, cm -1 ): 3442 (-OH), 2254 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C), 1549 (-C=C, -C=N); 1 H NMR (DMSO- d 6 ): 11.8 (s, OH), 8.35 (s, H exocyclic ethylene), 6.23-7.55 (m, 3H coumarin ring), 8.14 (s, H, imidazole), 7.4 (d, H, imidazole), 7.14 (d, H, imidazole), 2.45 (s, 3H, -CH 3 ); 13 C NMR(DMSO- d 6 ): δ 189.7 (C, -CO), 162 (C, exocyclic ethylene), 160.5 (C-2), 155 (C-7), 153 (C-4), 136.7 (C, imidazole), 130.0 (C, imidazole), 146 (C-10), 125.2 (C-5), 117.5 (C, imidazole), 118.2 (C-8), 115 (-CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 104 (C, ethylene), 19.5 (C, -CH 3 ); MS: m/z(M + +1): 322.3; Anal. Calcd for C 17 H 11 N 3 O 4 : C, 63.55; H, 3.45; N, 13.08; O, 19.92. Found; C, 63.45; H, 3.40; N, 13.11; O, 20.05.
- (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)-N-(2-hydroxyethyl)acrylamide (7k)
IR (KBr, cm -1 ): 3442 (-OH), 2254 (-CN), 1742 (-CO), 1594 (-C=C), 1549 (-C=C); 1 H NMR (DMSO- d 6 ): δ 11.8 (s, OH), 8.9 (t, -NH), 8.35 (s, H exocyclic ethylene), 6.23-7.55 (m, 3H coumarin ring), 4.8 (s, -OH, aliphatic), 3.6 (t, 2H, -CH 2 -O), 3.4 (t, 2H, N-CH 2 -), 2.45 (s, 3H, -CH 3 ); 13 C NMR (DMSO- d 6 ): δ 161 (C-2), 159 (CO), 155 (C-7), 154 (C, exocyclic ethylene), 153 (C-4), 146.2 (C-10), 125.5 (C-5), 118.5 (C-8), 115 (-CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 104 (C, ethylene), 61.0 (C-OH), 42 (-NH-C), 19.5 (C, -CH 3 ); MS: m/z(M + +1): 315.3; Anal. Calcd for C 16 H 14 N 2 O 5 : C, 61.14; H, 4.49; N, 8.91; O, 25.45. Found; C, 61.25; H, 4.50; N, 9.00; O, 25.55.
- (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)acrylamide(7l)
IR (KBr, cm -1 ): 3442 (-OH), 3225 (-NH), 2254 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C), 1549 (-C=C); 1 H NMR(DMSO- d 6 ): 11.8 (s, OH), 8.35 (s, H exocyclic ethylene), 7.66 (s, 2H, -NH 2 ), 6.23-7.55 (m, 3H coumarin ring), 2.45 (s, 3H, -CH 3 ); 13 C NMR (DMSO- d 6 ): δ 1647 (CO), 154 (C, exocyclic ethylene), 160.5 (C-2), 155 (C-7), 153 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-8), 115 (-CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 106 (C, ethylene), 19.5 (C, -CH 3 ); MS: m/z(M + +1): 271.24; Anal. Calcd for C 14 H 10 N 2 O 4 : C, 62.22; H, 3.73; N, 10.37; O, 23.68. Found; C, 62.45; H, 3.54; N, 10.27; O, 23.70.
- (E)-N-benzhydryl-2-cyano-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)acrylamide (7m)
IR (KBr, cm -1 ): 3442 (-OH), 2254 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C), 1549 (-C=C); 1 H NMR (DMSO- d 6 ): 11.8 (s, OH), 8.35 (s, H exocyclic ethylene), 8.0 (s, H, -NH), 6.23-7.55 (m, 3H coumarin ring), 7.22-7.44 (m, 10H, benzhydril), 6.16 (s, H,-CH), 2.45 (s, 3H, -CH 3 ); 13 C NMR(DMSO- d 6 ): δ 161 (C-2), 160 (C, exocyclic ethylene), 159 (CO), 155 (C-7), 153 (C-4), 146 (C-10), 141.2 (C-4', C-4''), 128 (C-5', C-5'', C-3', C-3''), 129.2 (C-6', C-6'', C-2', C-2''), 126.2 (C-1', C-1''), 125.2 (C-5), 118.2 (C-8), 115 (-CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 104 (C, ethylene), 52.5 (C, -CH of benzhydril), 19.5 (C, -CH 3 ); MS: m/z(M + +1): 437.5; Anal. Calcd for C 27 H 20 N 2 O 4 : C, 74.30; H, 4.62; N, 6.42; O, 14.66. Found; C, 74.25; H, 4.66; N, 4.56; O, 14.56.
- (E)-2-cyano-N-(2,4-dimethoxybenzyl)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl) acrylamide (7n)
IR (KBr, cm -1 ): 3442 (-OH), 2254 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C), 1549 (-C=C); 1 H NMR (DMSO- d 6 ): 11.8 (s, OH), 10.5 (s, -NH), 8.35 (s, H exocyclic ethylene), 8.1 (d, H of C-3'), 6.23-7.55 (m, 3H coumarin ring), 6.53-6.8 (2H, of C-2', C-6'), 3.8 (s, 6H of -OCH 3 ), 2.4 (s, 3H, -CH 3 ); 13 C NMR(DMSO- d 6 ): δ 169 (C-1'), 64 (C, -CO), 160.5 (C-2), 155 (C-7), 153.6 (C, exocyclic ethylene), 154 (C-4, C-5'), 146 (C-10), 125.2 (C-5), 123 (C-3'), 118.2 (C-8), 117 (C-4'), 115 (-CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 106 (C-2'), 104 (C, ethylene), 100 (C-6'), 56 (2C, -OCH 3 ), 19.5 (C, -CH 3 ); MS: m/z (M + +1): 407.4; Anal. Calcd for C 22 H 18 N 2 O 6 : C, 65.02; H, 4.46; N, 6.89; O, 23.62. Found; C, 65.07; H, 4.52; N, 6.79; O, 23.90.
- (E)-2-cyano-N-(4,5-dihydrothiazol-2-yl)-3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-8-yl) acrylamide (7o)
IR (KBr, cm -1 ): 3442 (-OH), 2254 (-CN), 1742 (-CO), 1644 (cyclic -CO), 1594 (-C=C), 1549 (-C=C), 750 (C-S); 1 H NMR (DMSO- d 6 ): 11.8 (s, OH), 8.45 (s, H exocyclic ethylene), 8.0 (s, H, -NH), 6.23-7.55 (m, 3H coumarin ring), 3.8 (t, 2H, -N-CH 2 -), 3.25 (t, 2H, -S-CH 2 ), 2.45 (s, 3H, -CH 3 ); 13 C NMR (DMSO- d 6 ): δ 169 (CO), 163.5 (-N- C = N), 162 (C, exocyclic ethylene), 160.5 (C-2), 155 (C-7), 153 (C-4), 146 (C-10), 125.2 (C-5), 118.2 (C-8), 115 (-CN), 114.6 (C-6), 112.5 (C-3), 112.0 (C-9), 106 (C, ethylene), 54 (=N- C H 2 ), 24 (-S- C H 2 ), 19.5 (C,-CH 3 ); MS: m/z(M + +1): 356.37; Anal. Calcd for C 17 H 13 N 3 O 4 S: C, 57.46; H, 3.69; N, 11.82; O, 18.01; S, 9.02. Found; C, 58.02; H, 3.70; N, 11.90; O, 18.20; S, 9.10.
RESULTS AND DISCUSSION
In this paper we reported that synthesis of some novel coumarin derivatives (7a-o) Resorcinol (1) reacts with ethyl acetoacetate in sulfuric acid and gives 7-hydroxy-4-methyl coumarin (2) . The structure of 2 was established by IR, 1 H NMR and MS studies. It showed strong IR absorption bands at 3423, 1733, 1555 cm -1 due to enol, coumarin carbonyl and alkene groups respectively. In its 1 H NMR spectrum three singlets at δ 2.49, 6.31 and 6.94 were assigned to a methyl group, olefinic proton and an aromatic proton respectively. Two aromatic protons of coumarin moiety appeared as doublets at 6.92, 7.57. Refluxing of (2) and hexamethylene tetramine in glacial acetic acid for 6 hours afforded 8-formyl-4-methyl-7-hydroxy Coumarin (3) . The structure of (3) was established on the basis of IR, 1 H NMR and MS data. Presence of a singlet peak in its 1 H NMR spectrum at 10.63 confirms the formyl group.
Synthesis of 7a-o
PPT Slide
Lager Image
Synthesis of 7a-o
Refluxing of amines (5a-o) with ethyl cyano acetate (4) for 5 hours yielded N,N di substituted cyanoacetamide derivatives (6a-o) . The condensation of (3) and (6a-o) in ethanol using catalytic amount of Piperidine for 2 hours gave corresponding coumarin derivatives (7a-o) . The structures of (7a-o) were established on the basis of IR, 1 H NMR, 13 C NMR, mass spectral data and elemental analysis.
Acknowledgements
The authors express their grateful thanks to Prof. C.D. Reddy, Department of Chemistry, Sri Venkateswara University, Tirupati, for his helpful discussions.
References
Madhavi D. , Pushpa P. , Mary J. , Usha P. , Rajashree K. , Nirmala D. 2008 Indian J. Exp. Biol. 46 788 -
Mulwad V. V. , Shirodkar J. M. 2002 Ind. J. Heterocycl. Chem. 11 192 -
Manohar K. , Manjunath G. , Raviraj K. 2004 Indian J. Heterocycl. Chem. 14 201 -
Rajeshwarrao V. , Srimanth K. , Vijayakumar P. 2004 Indian J. Heterocycl. Chem. 14 141 -
Nofal Z. M. , El-Zahar M. I. , Abd, El-Karin S. S. 2005 J. Antimicrob. Chemother. 5 483 -
Bhattacharyya S. S. , Paul S. , Mandal K. S. , Antara B. , Naoual B. , Anisur R. K.-B. 2009 Eur. J. Phram. 614 128 -    DOI : 10.1016/j.ejphar.2009.04.015
Pechmann H. , Duisberg C. 1883 Ber. Dtsch. Chem. Ges. 16 2119 -    DOI : 10.1002/cber.188301602117
Patel A. D. , Sharma M. S. , Vohra J. J. , Joshi J. D. 1997 J. Indian Chem. Soc. 74 287 -
Wang K. , Nguyen K. , Huang Y. , Domling A. 2009 Journal of Combinatorial Chemistry 11 920 -    DOI : 10.1021/cc9000778
Tamiz A. P. , Cai S. X. , Zhou Z. L. , Yuen P. W. , Schelkun R. M. , Whittemore E. R. , Weber E. , Woodward R. M. , Keana J. F. W. 1999 J. Med. Chem. 42 3412 -    DOI : 10.1021/jm990199u
McChuskey A. , Robinson P. J. , Hill T. , Scott J. L. , Edwards J. K. 2002 Tettrahedron Lett. 43 3117 -    DOI : 10.1016/S0040-4039(02)00480-X